I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
D. Petrylak
346
results:
Search for persons
X
Format
Online (346)
Mediatypes
E-Books (1)
Articles (Online) (182)
Bookchapter (Online) (1)
OpenAccess-fulltext (162)
Sorted by: Relevance
Sorted by: Year
?
1
Clinical outcomes of patients with metastatic Hormone-Sensi..:
Stenzl, A.
;
Shore, N.D.
;
Villers, A.
...
European Urology. 81 (2022) - p. S776-S777 , 2022
Link:
https://doi.org/10.1016/..
?
2
ARCHES: Efficacy of androgen deprivation therapy (ADT) with..:
Stenzl, A.
;
Szmulewitz, R.Z.
;
Petrylak, D.
...
European Urology Open Science. 19 (2020) - p. e865-e866 , 2020
Link:
https://doi.org/10.1016/..
?
3
Phase 3 study of androgen deprivation therapy (ADT) with en..:
Basso, U.
;
Galetti, T. Prayer
;
Armstrong, A.
...
European Urology Supplements. 18 (2019) 9 - p. e3258 , 2019
Link:
https://doi.org/10.1016/..
?
4
A phase 3 study to evaluate enfortumab vedotin (EV) versus ..:
Petrylak, D.
;
Rosenberg, J.
;
Duran, I.
...
European Urology Supplements. 18 (2019) 1 - p. e1836-e1837 , 2019
Link:
https://doi.org/10.1016/..
?
5
EV-201 Study: A single-arm, open-label, multicenter study o..:
Rosenberg, J.
;
Balar, A.
;
O'Donnell, P.
...
European Urology Supplements. 17 (2018) 2 - p. e1152 , 2018
Link:
https://doi.org/10.1016/..
?
6
Healthcare resource utilization in RANGE: Ramucirumab plus ..:
Bamias, A.
;
Van Der Heijden, M.
;
De Wit, R.
...
European Urology Supplements. 17 (2018) 2 - p. e140-e141 , 2018
Link:
https://doi.org/10.1016/..
?
7
EV-103 Study: A phase 1b dose-escalation and dose-expansion..:
Hoimes, C.J.
;
Petrylak, D.
;
Flaig, T.
...
European Urology Supplements. 17 (2018) 2 - p. e1151 , 2018
Link:
https://doi.org/10.1016/..
?
8
Pembrolizumab vs investigator-choice chemotherapy for previ..:
Necchi, A.
;
Bellmunt, J.
;
De Wit, R.
...
European Journal of Cancer. 72 (2017) - p. S2 , 2017
Link:
https://doi.org/10.1016/..
?
9
21LBA Atezolizumab in patients (pts) with locally-advanced ..:
Rosenberg, J.
;
Petrylak, D.
;
Abidoye, O.
...
European Journal of Cancer. 51 (2015) - p. S720 , 2015
Link:
https://doi.org/10.1016/..
?
10
2526 Immune responses and clinical data from STRIDE, a rand..:
Petrylak, D.
;
Quinn, D.
;
Dreicer, R.
...
European Journal of Cancer. 51 (2015) - p. S483 , 2015
Link:
https://doi.org/10.1016/..
?
11
2637 Baseline circulating tumor cells (CTC) and serum heat ..:
Petrylak, D.
;
Eigl, B.
;
Senkus, E.
...
European Journal of Cancer. 51 (2015) - p. S525 , 2015
Link:
https://doi.org/10.1016/..
?
12
870 A phase 2 trial of prostate specific membrane antigen a..:
Petrylak, D.
;
Smith, D.C.
;
Appleman, L.J.
...
European Urology Supplements. 13 (2014) 1 - p. e870 , 2014
Link:
https://doi.org/10.1016/..
?
13
Prognostic Model Predicting Metastatic Castration-Resistant..:
Halabi, S.
;
Lin, C.-Y.
;
Small, E. J.
...
JNCI Journal of the National Cancer Institute. 105 (2013) 22 - p. 1729-1737 , 2013
Link:
https://doi.org/10.1093/..
?
14
244 Prostate Specific Membrane Antigen Antibody Drug Conjug..:
Petrylak, D.
;
Kantoff, P.
;
Mega, A.
...
European Journal of Cancer. 48 (2012) - p. 75 , 2012
Link:
https://doi.org/10.1016/..
?
15
P114 Safety and efficacy of orteronel (TAK-700), an oral, i..:
Petrylak, D.
;
Gandhi, J.
;
Clark, W.R.
...
European Urology Supplements. 11 (2012) 5 - p. 230 , 2012
Link:
https://doi.org/10.1016/..
1-15